Galmed Pharmaceuticals Ltd (GLMD)
0.3877
+0.02
(+6.48%)
USD |
NASDAQ |
Apr 24, 16:00
0.3877
0.00 (0.00%)
After-Hours: 20:00
Galmed Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
Date | Value |
---|---|
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
Compugen Ltd | 0.00 |
Pluri Inc | 5.547 |
BioLine Rx Ltd | 0.7391 |
Can Fite Biofarma Ltd | 0.00 |
BiomX Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 16.63M |
Total Liabilities (Quarterly) | 2.75M |
Shareholders Equity (Quarterly) | 13.88M |